Targeted therapies for bone sarcomas

di Heymann, Dominique, Rédini, Françoise
Pubblicazione 2013

Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma

di Redini, Françoise, Heymann, Dominique
Pubblicato in Front Oncol (2015)

Transforming Growth Factor-β Signaling Plays a Pivotal Role in the Interplay Between Osteosarcoma Cells and Their Microenvironment

di Verrecchia, Franck, Rédini, Françoise
Pubblicato in Front Oncol (2018)

RANKL/RANK/OPG: key therapeutic target in bone oncology

di Ando, Kosei, Mori, Kanji, Rédini, Françoise, Heymann, Dominique
Pubblicazione 2008

TRAIL receptor signaling and therapeutic option in bone tumors: the trap of the bone microenvironment

di Picarda, Gaëlle, Trichet, Valérie, Téletchéa, Stéphane, Heymann, Dominique, Rédini, Françoise
Pubblicazione 2011

Mifamurtide for the treatment of nonmetastatic osteosarcoma

di Ando, Kosei, Mori, Kanji, Corradini, Nadège, Redini, Françoise, Heymann, Dominique
Pubblicazione 2011

SHH Signaling Pathway Drives Pediatric Bone Sarcoma Progression

di Lézot, Frédéric, Corre, Isabelle, Morice, Sarah, Rédini, Françoise, Verrecchia, Franck
Pubblicato in Cells (2020)

The Osteosarcoma Microenvironment: A Complex but Targetable Ecosystem

di Corre, Isabelle, Verrecchia, Franck, Crenn, Vincent, Redini, Francoise, Trichet, Valérie
Pubblicato in Cells (2020)

Antagonistic Functions of Connexin 43 during the Development of Primary or Secondary Bone Tumors

di Talbot, Julie, Dupuy, Maryne, Morice, Sarah, Rédini, Françoise, Verrecchia, Franck
Pubblicato in Biomolecules (2020)

New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?

di Danieau, Geoffroy, Morice, Sarah, Rédini, Françoise, Verrecchia, Franck, Brounais-Le Royer, Bénédicte
Pubblicato in Int J Mol Sci (2019)

Hippo/YAP Signaling Pathway: A Promising Therapeutic Target in Bone Paediatric Cancers?

di Morice, Sarah, Danieau, Geoffroy, Rédini, Françoise, Brounais-Le-Royer, Bénédicte, Verrecchia, Franck
Pubblicato in Cancers (Basel) (2020)

Molecular Alterations Associated with Osteosarcoma Development

di Ando, Kosei, Mori, Kanji, Verrecchia, Franck, Marc, Baud'huin, Rédini, Françoise, Heymann, Dominique
Pubblicazione 2012

Current Therapeutic Strategies and Novel Approaches in Osteosarcoma

di Ando, Kosei, Heymann, Marie-Françoise, Stresing, Verena, Mori, Kanji, Rédini, Françoise, Heymann, Dominique
Pubblicazione 2013

Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases

di Lamora, Audrey, Mullard, Mathilde, Amiaud, Jérôme, Brion, Régis, Heymann, Dominique, Redini, Françoise, Verrecchia, Franck
Pubblicato in Oncotarget (2015)

TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression

di Lamora, Audrey, Talbot, Julie, Mullard, Mathilde, Brounais-Le Royer, Benedicte, Redini, Françoise, Verrecchia, Franck
Pubblicato in J Clin Med (2016)

A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis

di Le Goff, Benoit, Soltner, Elise, Charrier, Céline, Maugars, Yves, Rédini, Françoise, Heymann, Dominique, Berthelot, Jean-Marie
Pubblicazione 2009

Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models

di Gobin, Bérengère, Moriceau, Gatien, Ory, Benjamin, Charrier, Céline, Brion, Régis, Blanchard, Frederic, Redini, Françoise, Heymann, Dominique
Pubblicazione 2014

L-MTP-PE and zoledronic acid combination in osteosarcoma: preclinical evidence of positive therapeutic combination for clinical transfer

di Biteau, Kevin, Guiho, Romain, Chatelais, Mathias, Taurelle, Julien, Chesneau, Julie, Corradini, Nadège, Heymann, Dominique, Redini, Françoise
Pubblicato in Am J Cancer Res (2016)

Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma

di Lamoureux, Francois, Baud'huin, Marc, Ory, Benjamin, Guiho, Romain, Zoubeidi, Amina, Gleave, Martin, Heymann, Dominique, Rédini, Françoise
Pubblicazione 2014

Receptor Activator of Nuclear Factor κB Ligand (RANKL)/Osteoprotegerin (OPG) Ratio Is Increased in Severe Osteolysis

di Grimaud, Eva, Soubigou, Luc, Couillaud, Séverine, Coipeau, Patrick, Moreau, Anne, Passuti, Norbert, Gouin, François, Redini, Françoise, Heymann, Dominique
Pubblicazione 2003